Antazoline

Active ingredient description

Antazoline is an antagonist of histamine H1 receptors. It selectively bind to but does not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine, which subsequently leads to temporary relief of the negative symptoms brought on by histamine.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
R01AC04
Antazoline
R Respiratory system → R01 Nasal preparations → R01A Decongestants and other nasal preparations for topical use → R01AC Antiallergic agents, excl. corticosteroids
Discover more medicines within R01AC04
R06AX05
Antazoline
R Respiratory system → R06 Antihistamines for systemic use → R06A Antihistamines for systemic use → R06AX Other antihistamines for systemic use
Discover more medicines within R06AX05

Medicines

Antazoline is the active ingredient of these drugs:

Drug
Countries
PHENAZOLINUM

Poland

Antazoline is also found within below combination drugs:

ALBALON-A , ALERGOFTAL , ALLERGOPOS , ALLERTEC UKASZENIA , ALOSYN , CIBALLERGE , OCULERGE , OPSA-HIS , OPTIALERG , OTRIVINE ANTISTIN , SPERSALLERG , STARAZOLIN RED

Structural formula

Graphic representation of the active ingredient's molecular structure

Chemical formula: C₁₇H₁₉N₃
Molecular mass: 265.353 g/mol

External identifiers

CAS Substance: 2508-72-7
CAS Substance: 91-75-8
DrugBank Drug: DB08799
KEGG Drug: D07458
PubChem Compound: 2200
RxNorm Ingredient: 865
SNOMED-CT Concept: 373544004
Antazoline (substance)
UNII Identifier: DHA8014SS1
ANTAZOLINE
 
Next: Usage >